Sangamo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sangamo Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/24/2024 | PM | SGMO | Q1 | $0.12 | -$0.11 | — | — | $157.96M | $7.16M | — | — | Get Alert |
03/13/2024 | AM | SGMO | Q4 | -$0.32 | -$0.26 | -$0.34 | -30.77% | $27.23M | $8.10M | $2.04M | -74.79% | Get Alert |
11/01/2023 | PM | SGMO | Q3 | -$0.34 | -$0.32 | -$0.59 | -84.38% | $26.46M | $10.40M | $9.40M | -9.63% | Get Alert |
08/08/2023 | PM | SGMO | Q2 | -$0.29 | -$0.34 | -$0.37 | -8.82% | $29.38M | $14.83M | $6.83M | -53.91% | Get Alert |
04/26/2023 | PM | SGMO | Q1 | -$0.30 | -$0.33 | $0.12 | 136.36% | $28.23M | $24.06M | $157.96M | 556.51% | Get Alert |
02/22/2023 | PM | SGMO | Q4 | -$0.26 | -$0.36 | -$0.32 | 11.11% | $27.99M | $26.86M | $27.23M | 1.38% | Get Alert |
11/03/2022 | PM | SGMO | Q3 | -$0.33 | -$0.35 | -$0.34 | 2.86% | $28.56M | $26.59M | $26.46M | -0.49% | Get Alert |
08/04/2022 | PM | SGMO | Q2 | -$0.33 | -$0.35 | -$0.29 | 17.14% | $27.87M | $24.63M | $29.38M | 19.28% | Get Alert |
05/05/2022 | PM | SGMO | Q1 | -$0.32 | -$0.31 | -$0.30 | 3.23% | $26.28M | $27.29M | $28.23M | 3.45% | Get Alert |
02/24/2022 | PM | SGMO | Q4 | -$0.29 | -$0.34 | -$0.26 | 23.53% | $25.80M | $26.82M | $27.99M | 4.35% | Get Alert |
11/04/2021 | AM | SGMO | Q3 | -$0.01 | -$0.34 | -$0.33 | 2.94% | $57.76M | $25.19M | $28.56M | 13.39% | Get Alert |
08/05/2021 | PM | SGMO | Q2 | -$0.26 | -$0.31 | -$0.33 | -6.45% | $21.55M | $26.48M | $27.87M | 5.26% | Get Alert |
05/04/2021 | PM | SGMO | Q1 | -$0.37 | -$0.30 | -$0.32 | -6.67% | $13.08M | $23.98M | $26.28M | 9.59% | Get Alert |
02/24/2021 | PM | SGMO | Q4 | $0.04 | -$0.21 | -$0.29 | -38.10% | $54.85M | $32.15M | $25.80M | -19.75% | Get Alert |
11/04/2020 | PM | SGMO | Q3 | -$0.24 | — | -$0.01 | — | $21.96M | — | $57.76M | — | Get Alert |
08/05/2020 | PM | SGMO | Q2 | -$0.26 | — | -$0.26 | — | $17.55M | — | $21.55M | — | Get Alert |
05/11/2020 | PM | SGMO | Q1 | -$0.41 | -$0.29 | -$0.37 | -27.59% | $8.07M | $22.74M | $13.08M | -42.50% | Get Alert |
02/28/2020 | AM | SGMO | Q4 | -$0.18 | -$0.33 | $0.04 | 112.12% | $26.80M | — | $54.85M | — | Get Alert |
11/06/2019 | PM | SGMO | Q3 | -$0.13 | -$0.34 | -$0.24 | 29.41% | $23.56M | $12.16M | $21.96M | 80.58% | Get Alert |
Sangamo Therapeutics (SGMO) is scheduled to report earnings on April 24, 2024. The last reported earnings were for reported on March 13, 2024 for Q4.
The Actual EPS was $-0.34, which missed the estimate of $-0.26.
The Actual Revenue was $2M, which missed the estimate of $8.1M.
Browse earnings estimates, EPS, and revenue on all stocks.